New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

It’s a complex procedure used only for people who have severe sleep apnea and problems with their head or face. Obstructive sleep apnea happens when a structural problem makes it hard for you to ...

Obstructive sleep apnea (OSA)-induced biological changes include ... are also known risk factors for cardiovascular disease. Severe OSA-hypopnea significantly increases the risk of fatal and ...

On Friday, Dec. 20, the US regulator approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, which promises results along with ...

Obstructive sleep apnea syndrome in children is characterized ... and restless sleep. Children with severe nasal obstruction may open their mouths and hyperextend their necks to breathe ...

For people with untreated obstructive sleep apnea, getting a good night’s sleep is easier said than done. Having one’s airway become blocked multiple times a night is not only disruptive in the ...

A study has found that moderate-to-severe obstructive sleep apnea increases risk for incident myocardial infarction between 12 and 5:59 AM.